✦ LIBER ✦

374 Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh): impact of CYP2D6 genotype and side-effects on adherence rates

✍ Scribed by M. Hubalek

Book ID: 119601385
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 45 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)70400-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

377 Patient-reported outcomes in breast

377 Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh): adherence rates and symptom burden over the disease trajectory

✍ V. Meraner; A. Oberguggenberger; J. Giesinger; M. Hubalek; B. Beer; B. Schubert; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P294 What is the key issue to evaluate a

P294 What is the key issue to evaluate adherence to endocrine treatment in breast cancer patients? Methodological results of a prospective study: Patient-reported outcomes in breast cancer patients undergoing endocrine therapy (PRO-BETh)

✍ R. Achleitner; A. Oberguggenberger; V. Meraner; C. Marth; B. Beer; J. Giesinger; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Significant Effect of Polymorphisms in C

Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

✍ Kiyotani, K.; Mushiroda, T.; Imamura, C. K.; Hosono, N.; Tsunoda, T.; Kubo, M.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 256 KB